Acute progression of BCR-FGFR1 induced murine B-lympho/myeloproliferative disorder suggests involvement of lineages at the pro-B cell stage

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Ren, MingQiang ^a   Tidwell, Josephine A ^a   Sharma, Suash ^a   Cowell, John K ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CD45 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; IMMUNOGLOBULIN M; LEUKOSIALIN; FGFR1 PROTEIN, MOUSE; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW CELL; CELL LINE; CELL LINEAGE; DISEASE COURSE; IMMUNOPHENOTYPING; LEUKOCYTOSIS; LYMPHATIC LEUKEMIA; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRE B LYMPHOCYTE; SPLENOMEGALY; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW TRANSPLANTATION; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; FLOW CYTOMETRY; GENETICS; HISTOLOGY; IMMUNOLOGY; KARYOTYPING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALIA; MURINAE; MUS;

ANIMALS; ANTIGENS, CD19; ANTIGENS, CD43; ANTIGENS, CD45; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; CELL LINE, TUMOR; CELL LINEAGE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA PRIMERS; FLOW CYTOMETRY; HISTOLOGICAL TECHNIQUES; IMMUNOGLOBULIN M; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, B-CELL; MICE; MICE, INBRED BALB C; MYELOPROLIFERATIVE DISORDERS; PRECURSOR CELLS, B-LYMPHOID; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84862017445     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038265     Document Type: Article

References (21)

1. Abruzzo LV, Jaffe ES, Cotelingam JD, Whang-Peng J, Del Duca V Jr, et al. (1992) T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol 16: 236-245.
2. Tefferi A, Vardiman JW, (2008) Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 22: 14-22.
3. Tefferi A, Skoda R, Vardiman JW, (2009) Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol 6: 627-637.
4. Jackson CC, Medeiros LJ, Miranda RN, (2010) 8p11 myeloproliferative syndrome: a review. Hum Pathol 41: 461-476.
5. Agerstam H, Lilljebjorn H, Lassen C, Swedin A, Richter J, et al. (2007) Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 46: 635-643.
6. Baldazzi C, Iacobucci I, Luatti S, Ottaviani E, Marzocchi G, et al. (2010) B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene. Leuk Res 34: e282-285.
7. Demiroglu A, Steer EJ, Heath C, Taylor K, Bentley M, et al. (2001) The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 98: 3778-3783.
8. Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billstrom R, et al. (2001) Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Genes Chromosomes Cancer 32: 302-310.
9. Murati A, Arnoulet C, Lafage-Pochitaloff M, Adelaide J, Derre M, et al. (2005) Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion. Int J Oncol 26: 1485-1492.
10. Pini M, Gottardi E, Scaravaglio P, Giugliano E, Libener R, et al. (2002) A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p. Hematol J 3: 315-316.
11. Richebourg S, Theisen O, Plantier I, Parry A, Soenen-Cornu V, et al. (2008) Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia. Genes Chromosomes Cancer 47: 915-918.
12. Wakim JJ, Tirado CA, Chen W, Collins R, (2011) t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leuk Res 35: e151-153.
13. Kim SY, Oh B, She CJ, Kim HK, Jeon YK, et al. (2011) 8p11 Myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: a case report and review of the literature. Leuk Res 35: e30-34.
14. Roumiantsev S, Krause DS, Neumann CA, Dimitri CA, Asiedu F, et al. (2004) Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell 5: 287-298.
15. Ren M, Li X, Cowell JK, (2009) Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase. Blood 114: 1576-1584.
16. Williams DA, Tao W, Yang F, Kim C, Gu Y, et al. (2000) Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 96: 1646-1654.
17. Cowell JK, LaDuca J, Rossi MR, Burkhardt T, Nowak NJ, et al. (2005) Molecular characterization of the t(3;9) associated with immortalization in the MCF10A cell line. Cancer Genet Cytogenet 163: 23-29.
18. Chen Y, Hu Y, Michaels S, Segal D, Brown D, et al. (2009) Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice. Leukemia 23: 1446-1454.
19. Barabe F, Kennedy JA, Hope KJ, Dick JE, (2007) Modeling the initiation and progression of human acute leukemia in mice. Science 316: 600-604.
20. Wei J, Wunderlich M, Fox C, Alvarez S, Cigudosa JC, et al. (2008) Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell 13: 483-495.
21. Ren M, Cowell JK, (2011) Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease. Blood 117: 6837-6847.